Rheumatoid arthritis (RA) is a type of inflammatory arthritis that affects~ 1% of the general
population. Although arthritis is the cardinal symptom, many extra-articular manifestations …

Rheumatoid arthritis (RA) is an inflammatory autoimmune disease characterized by the
destruction of articular joint structures. RA is a systemic condition that often affects multiple …

Objective To review published cases of induced or exacerbated interstitial lung disease
(ILD) in rheumatoid arthritis (RA) associated with non-biologic disease-modifying …

Interstitial lung disease (ILD) is a severe rheumatoid arthritis (RA) manifestation. The worst
survival has been associated with usual interstitial pneumonia (UIP) definitive pattern in high …

Rheumatoid arthritis (RA) is a systemic autoimmune disease affecting 0.5–1% of the
worldwide population. Whilst predominantly causing chronic pain and inflammation in …

MTX, which is the anchor-drug for the treatment of RA, has been associated with lung injury
and in particular with MTX-related pneumonitis (M-pneu). Although the frequency of M-pneu …

Question addressed by the study Methotrexate (MTX) is a key anchor drug for rheumatoid
arthritis (RA) management. Fibrotic interstitial lung disease (ILD) is a common complication …

Interstitial lung disease (ILD) is a relevant extra‐articular manifestation of rheumatoid
arthritis (RA) that may occur either in early stages or as a complication of long‐standing …

The aim is to evaluate the published evidence on whether methotrexate (MTX) use causes
progressive fibrotic interstitial lung disease (fILD). This PRISMA-compliant systematic review …

Because the usual interstitial pneumonia pattern may be more frequent in rheumatoid
arthritis and some data suggest a poor prognosis for rheumatoid arthritis-associated …